# Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)

> **NCT05224960** · PHASE2 · RECRUITING · sponsor: **Beijing 302 Hospital** · enrollment: 140 (estimated)

## Conditions studied

- Decompensated Cirrhosis

## Interventions

- **BIOLOGICAL:** UC-MSCs
- **BIOLOGICAL:** Placebo(solution without UC-MSCs)

## Key facts

- **NCT ID:** NCT05224960
- **Lead sponsor:** Beijing 302 Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-27
- **Primary completion:** 2025-06-27
- **Final completion:** 2027-06-20
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2024-10-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05224960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05224960, "Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-2)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05224960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*